Alpine Immune Sciences Inc expected to post a loss of 40 cents a share - Earnings Preview

Alpine Immune Sciences

06/08/2021 12:56

* Alpine Immune Sciences Inc  ALPN.OQ   ALPN.O  is expected
to show a rise in quarterly revenue when it reports results on
August 9 (estimated). 
* The Seattle, Washington-based company is expected to report 
 a 838.6% increase in revenue to $6.477 million from $690
thousand a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Alpine Immune Sciences
Inc is for a loss of 40 cents per share. For the same quarter
last year, the company reported a loss of 53 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $21​, about 59.5% above​ its last closing price
of $8.50. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.36       -0.36      -0.45     Missed  -26.2
 Dec. 31 2020  -0.26       -0.31      -0.27     Beat    13.4
 Sep. 30 2020  -0.22       -0.23      -0.28     Missed  -20.4​
 Jun. 30 2020  0.04        0.54       -0.53     Missed  -199.1
 Mar.          -0.48​      -0.47      -0.30     Beat    36.2​
 31​ 2020​                                              
 Dec. 31 2019              -0.58      -0.33     Beat    43.6​
 Sep. 30 2019  -0.69       -0.68      -0.62     Beat    8.8
 Jun. 30 2019  -0.68       -0.68      -0.64     Beat    5.5
 This summary was machine generated August 6 at 11:56 GMT.  All
figures in US dollars unless otherwise stated